Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 15/20 | 0.36 |
| ▸ | CA1 | P00915 | 14/20 | 0.36 |
| ▸ | MMP1 | P03956 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.36 |
| ▸ | MMP8 | P22894 | 2/20 | 0.36 |
| ▸ | MMP13 | P45452 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7782672 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL955674 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL7779859 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL536269 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL428315 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL465610 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL953593 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL7779621 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL957654 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| Water SCHEMBL11048628 | 0.97 | THRB (0.59) | THRBLMNACA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115073712-A | Preparation method and application of low-chlorine epoxy resin | 杜彪 | 2022-09-20 | — | — | CN | claimed |
| CN-118139839-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-06-04 | — | — | CN | disclosed |
| CN-118055920-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-05-17 | — | — | CN | disclosed |
| CN-114790132-B | Fluorine-containing aldehyde and preparation method thereof | 三明学院 | 2024-03-22 | — | — | CN | disclosed |
| CN-115850542-B | Perfluoropolymer surfactant and preparation method and application thereof | 苏州润邦半导体材料科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-115850542-A | Perfluoro polymer surfactant and preparation method and application thereof | 苏州润邦半导体材料科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-110770200-B | Process for preparing polyfluorinated allyl ethers and compounds related thereto | 3M创新有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-20220289785-A1 | NOVEL TETRAGALNAC AND PEPTIDE CONTAINING CONJUGATES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES | BANK OF AMERICA, N.A. | 2022-09-15 | — | — | US | disclosed |
| CN-114790132-A | Fluorine-containing aldehyde and preparation method thereof | 三明学院 | 2022-07-26 | — | — | CN | disclosed |
| US-11292763-B2 | Methods of making a polyfluorinated allyl ether and compounds relating to the methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-04-05 | — | — | US | disclosed |
| EP-0935486-A1 | AQUEOUS FILM-FORMING FOAM COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998019988-A1 | ALPHA-BRANCHED FLUOROALKYLCARBONYL FLUORIDES AND THEIR DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |
| WO-1998019742-A1 | AQUEOUS FILM-FORMING FOAM COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |
| US-5466877-A | Fluorination with deesterification and alkylation | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-11-14 | — | — | US | disclosed |
| WO-1995025082-A1 | PROCESS FOR CONVERTING PERFLUORINATED ESTERS TO PERFLUORINATED ACYL FLUORIDES AND/OR KETONES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-09-21 | — | — | WO | disclosed |
| US-4349650-A | Polyfluoroallyloxy compounds, their preparation and copolymers therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-09-14 | — | — | US | disclosed |
| US-4292449-A | Polyfluoroallyloxy compounds, their preparation and copolymers therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-09-29 | — | — | US | disclosed |
| US-4275225-A | Polyfluoroallyloxy compounds, their preparation and copolymers therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4273729-A | CARBONYL OR SULFONYL FLUORIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
| US-4273728-A | NITRILES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289785-A1 | NOVEL TETRAGALNAC AND PEPTIDE CONTAINING CONJUGATES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES | GALNT3, CSGALNACT1, FUT6 | THRB 254/4885LMNA 1907/4885CA2 3281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.